Literature DB >> 19218547

Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade.

Shinsuke Yamanda1, Satoru Ebihara, Masanori Asada, Tatsuma Okazaki, Kaijun Niu, Takae Ebihara, Akemi Koyanagi, Noriko Yamaguchi, Hideo Yagita, Hiroyuki Arai.   

Abstract

Delta-like 4 (DLL4) is one of the Notch ligands and plays an important role in vascular development. DLL4 blockade inhibits tumor growth by promoting nonproductive angiogenesis, which is characterized by an increase in vascular density and decrease in tissue perfusion. However, a detailed mechanism remains unclear. In this study, newly developed neutralizing antibodies against mouse and human DLL4 were used to investigate the possible involvement of VEGF-DLL4-ephrinB2 cascade in nonproductive angiogenesis caused by DLL4 blockade. DLL4 blockade and soluble ephrinB2 treatment suppressed tumor growth and induced nonproductive angiogenesis. DLL4 was expressed in subcutaneous tumors, and DLL4 blockade suppressed ephrinB2 expression in the tumors. DLL4 blockade significantly promoted human umbilical vein endothelial cell (HUVEC) proliferation in vitro, and the effect was additive to that of VEGF. Both DLL4 blockade and VEGF significantly increased cord length and branch points in a tubular formation assay. Expression of ephrinB2 in HUVECs was enhanced by VEGF alone, and the enhancement was inhibited by DLL4 blockade. Moreover, when we studied the effect of ephrinB2 RNA interference on HUVEC tubular formation, knockdown of ephrinB2 mimicked the effect of DLL4. These results suggest that ephrinB2 plays a crucial role in nonproductive angiogenesis caused by DLL4 blockade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218547     DOI: 10.1182/blood-2008-07-170381

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure.

Authors:  Jun-Ichiro Koga; Toshiaki Nakano; James E Dahlman; Jose-Luiz Figueiredo; Hengmin Zhang; Julius Decano; Omar F Khan; Tomiharu Niida; Hiroshi Iwata; Jon C Aster; Hideo Yagita; Daniel G Anderson; C Keith Ozaki; Masanori Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-24       Impact factor: 8.311

Review 2.  Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

Authors:  Daiju Fukuda; Masanori Aikawa
Journal:  Circ J       Date:  2013-09-12       Impact factor: 2.993

3.  Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.

Authors:  Ribal Bassil; Bing Zhu; Youmna Lahoud; Leonardo V Riella; Hideo Yagita; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

4.  Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.

Authors:  Yanyang Tu; Shiming He; Jianfang Fu; Gang Li; Ruxiang Xu; Hongliu Lu; Jianping Deng
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

5.  Beneficial effects of sunitinib on tumor microenvironment and immunotherapy targeting death receptor5.

Authors:  Yoko Tsukita; Tatsuma Okazaki; Satoru Ebihara; Riyo Komatsu; Mayumi Nihei; Makoto Kobayashi; Taizou Hirano; Hisatoshi Sugiura; Tsutomu Tamada; Nobuyuki Tanaka; Yasufumi Sato; Hideo Yagita; Masakazu Ichinose
Journal:  Oncoimmunology       Date:  2018-11-13       Impact factor: 8.110

6.  Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells.

Authors:  Liliana Mendonça; Alexandre Trindade; Catarina Carvalho; Jorge Correia; Marina Badenes; Joana Gigante; António Duarte
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

7.  The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.

Authors:  Lijun Meng; Zhenjiang Bai; Shan He; Kazuhiro Mochizuki; Yongnian Liu; Janaki Purushe; Hongxing Sun; Jian Wang; Hideo Yagita; Shin Mineishi; Henry Fung; Gregory A Yanik; Roberto Caricchio; Xiaoxuan Fan; Lisa M Crisalli; Elizabeth O Hexner; Ran Reshef; Yanyun Zhang; Yi Zhang
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

8.  Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.

Authors:  Daiju Fukuda; Elena Aikawa; Filip K Swirski; Tatiana I Novobrantseva; Victor Kotelianski; Cem Z Gorgun; Aleksey Chudnovskiy; Hiroyuki Yamazaki; Kevin Croce; Ralph Weissleder; Jon C Aster; Gökhan S Hotamisligil; Hideo Yagita; Masanori Aikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-13       Impact factor: 11.205

9.  Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.

Authors:  Kazuhiro Mochizuki; Fang Xie; Shan He; Qing Tong; Yongnian Liu; Izumi Mochizuki; Yajun Guo; Koji Kato; Hideo Yagita; Shin Mineishi; Yi Zhang
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

10.  Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.

Authors:  Luke T Krebs; Christa Starling; Alexander V Chervonsky; Thomas Gridley
Journal:  Genesis       Date:  2010-03       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.